Home > Journals > Minerva Surgery > Past Issues > Articles online first > Minerva Surgery 2022 Jul 05

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

Original Article   

Minerva Surgery 2022 Jul 05

DOI: 10.23736/S2724-5691.22.09580-6

Copyright © 2022 EDIZIONI MINERVA MEDICA

language: English

The effect of Roux-en-Y gastric bypass compared with omega-loop gastric bypass on weight loss, perioperative surgical events, and comorbidities

Omar THAHER 1 , Roland S. CRONER 2, Martin HUKAUF 3, Jamal DRIOUCH 1, Christine STROH 4

1 Department of Surgery, Marien Hospital Herne, Ruhr-Universität Bochum, Herne, Germany; 2 Department of General, Visceral, Vascular and Transplant Surgery, University Hospital Magdeburg, Magdeburg, Germany; 3 StatConsult Society for Clinical and Health Services Research GmbH, Magdeburg, Germany; 4 Department of General, Abdominal and Pediatric Surgery, Municipal Hospital, Gera, Germany


PDF


BACKGROUND: In comparison to conservative therapy, bariatric surgery has shown many reasonable results. The current study investigates whether Omega-Loop-Gastric-Bypass (OAGB) or Roux-en-Y Gastric-Bypass (RYGB) improves weight loss,
comorbidities, and perioperative complications.
METHODS: 28,683 patients after RYGB and OAGB were included in our study. Outcome criteria were perioperative morbidity, perioperative complications, and remission of comorbidities after one year of follow-up.
RESULTS: 14,253 patients had completed a one-year follow-up (13,483 patients by RYGB and 770 by OAGB). BMI reduction was a significant difference in favor of OAGB (17.5 ± 5.6 kg/m2 for OAGB vs. 15.2 ± 5.0 for RYGB; p<0.001). The %EWL was not significantly different between the two groups (p=0.073). There was also no significant difference in perioperative complications between the two groups (overall p>5%). Significant differences in favor of OAGB were observed in remission of insulin-dependent diabetes mellitus (IDDM) (p<0.001), and sleep apnea (p=0.002). Remission of reflux was more observed in RYGB than OAGB (p<0.001). Operating time was significantly higher in RYGB than OAGB (p<0.001).
CONCLUSIONS: Compared with RYGB, OAGB showed significant advantages in many respects. In particular, remission of comorbidities was significantly better after OAGB than in patients after RYGB during the one-year follow-up period. Nevertheless, many other factors such as medical history, long-term expected goals of bariatric surgery, and preexisting comorbidities should be taken into account when determining indications between the two procedures. Further studies with longer follow-up periods should be conducted to determine the efficacy of the two methods more accurately.


KEY WORDS: Gastric Bypass; Omega-loop-gastric-bypass; Follow-up; Perioperative complications; Comorbidities

top of page